Compare PLXS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLXS | RGEN |
|---|---|---|
| Founded | 1979 | 1981 |
| Country | United States | United States |
| Employees | 20000 | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.6B |
| IPO Year | 1995 | 1995 |
| Metric | PLXS | RGEN |
|---|---|---|
| Price | $285.36 | $145.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $206.50 | $167.67 |
| AVG Volume (30 Days) | 274.0K | ★ 971.4K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 56.11 | ★ 286.96 |
| EPS | ★ 3.32 | 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $14.31 | $14.30 |
| Revenue Next Year | $8.29 | $14.52 |
| P/E Ratio | ★ $89.39 | $968.40 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $115.83 | $100.99 |
| 52 Week High | $307.06 | $175.77 |
| Indicator | PLXS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 70.07 |
| Support Level | $269.81 | $141.44 |
| Resistance Level | $292.33 | $172.45 |
| Average True Range (ATR) | 11.23 | 6.22 |
| MACD | -1.35 | 1.41 |
| Stochastic Oscillator | 41.18 | 85.92 |
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.